Nuvation Bio Inc
Nuvation Bio Inc (NUVB) Implied Volatility Current
NUVB implied volatility is 79%. IV Rank is 15%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking NUVB implied volatility helps you identify when options premiums on Nuvation Bio Inc are historically cheap or expensive, and where the best trades are hiding. Nuvation Bio Inc implied volatility reflects the market's expectation of future price movement: when NUVB IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Nuvation Bio Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For NUVB, tracking metrics like NUVB IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on NUVB signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer.
The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where NUVB implied volatility sits today versus where it has been. Our scanner ranks Nuvation Bio Inc implied volatility against its historical range, surfaces extremes in NUVB IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Nuvation Bio Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 22, 2026
Trade options with IV on your side
Track NUVB IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→